• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/11

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

11 Cards in this Set

  • Front
  • Back

What are the 9 methods of drug administration?

Oral, sublingual, intravenous, topical, inhalation, subcutaneous, intramuscular, transdermal, rectal

Describe the FDA drug approval process

1.) Pre-clinical studies in vitro and animals


2.) Clinical trials in healthy patients and target patient population



Describe the different phases of clinical trials

Phase 1: testing in healthy volunteers


Phase 2a: testing in target population to ensure efficacy


Phase 2b: dose ranging studies to determine upper/lower limits of therapeutic and adverse effects


Phase 3: large multicenter trial to test safety and efficacy in patient population


Phase 4: Post-marketing surveillance

What is pharmokinetics?

How body interacts with drug (absorption, distribution, metabolism, secretion)

What is pharmodynamics?

How drug interacts with body (receptor interactions, dose-response, mechanisms of action for therapeutic and adverse effects)

List the routes of drug administration in order from fastest to slowest

Transdermal < Topical < Oral < rectal < SC < IM < sublingual < Inhalant < IV

What is the first pass effect?

This occurs when the drug is eliminated before it reaches circulation. Drugs taken get absorbed into the hepatic portal from the celiac, inferior/superior mesenteric veins. Enzymes in the stomach and intestine can metabolize most of the drug before they can reach the bloodstream

Why does the addition of a fixed concentration of an irreversible pharmacologic antagonist to increasing concentrations of an agonist decrease the apparent efficacy of an agonist?

The antagonist reduces the number of receptors available to the agonist for activation and signal transduction. The effect of a drug is proportional to the number of receptors activated.

Why does the addition of a fixed concentration of a reversible competitive pharmacologic antagonist to increasing concentrations of an agonist decrease the apparent potency of the agonist?

The presence of the antagonist effectively decreases the binding affinity of the receptor for the agonist. Potency is determined by affinity of the receptor for the drug.

What are the components of pharmacodynamics?

Concentration-response, properties of drug receptors, types of drug-receptor interactions

What are the components of pharmacokinetics

Absorption of drugs, distribution of drugs, elimination of drugs, pharmacokinetic calculations (dosages)